Search

everythinglearnresearchcommunity

for

Search:↓

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Glioblastoma cells can make androgens, which might help the tumor grow.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.